Search PubMed⌕ Search

Biomedical subjects

M B Pepys

Publications and source records attributed to M B Pepys.

At least 253 records · Page 14Linked to original sources

Radiometric ligand binding assay for C-reactive protein. Complexed C-reactive protein is not detectable in acute phase serum.

A radiometric ligand binding assay for human C-reactive protein (CRP) was established using pneumococcal C polysaccharide (CPS) coupled to magnetizable cellulose particles as the solid phase ligand. Competition for binding to the solid phase between 125I-CRP and unlabelled CRP permitted detection of 30 micrograms/l of CRP and the precise assay of concentrations up to 3000 micrograms/l. Identical results were obtained when the assay was used to quantitate isolated pure CRP and pure CRP added to normal human serum. However in vitro addition of known ligands for CRP to acute phase serum resulted in lowering of the apparent CRP concentration in this assay and addition of as little as 1 microgram/l of free CPS or 1 mg/l of lecithin was demonstrable in this way. A combination of the ligand binding assay and the standard electroimmunoassay for CRP was therefore used to test acute phase sera for the presence of CRP complexed in vitro. No evidence of complexed CRP was detected among sera containing between 1-319 mg/l of CRP from patients with Hodgkin's disease (10), rheumatoid arthritis (10), Crohn's disease (19) and various microbial infections (11), including six with subacute bacterial endocarditis. Since it is likely that CRP does form complexes with its ligands in the plasma these results suggest that complexed CRP is rapidly cleared from the circulation.

Acute Disease↗

Solid phase radioimmunoassays for human C-reactive protein.

Two new, rapid and sensitive radioimmunoassays for human C-reactive protein (CRP) have been established using antiserum coupled to magnetizable cellulose particles, which facilitate phase separation. A single antibody method, using solid phase anti-CRP, provides a sensitivity of 50 microgram/l with a 1-h incubation time and intra- and inter-assay coefficients of variation of 10%. A double antibody method, using fluid phase rabbit anti-CRP serum and solid phase sheep anti-rabbit IgG serum, provides a sensitivity of 3 microgram/l with an overnight incubation and intra- and inter-assay coefficients of variation of 10%. Among 468 sera from normal adult volunteer blood donors the median CRP concentration was 800 microgram/l, interquartile range 340-1700 microgram/l and range 70-29,000 microgram/l. Ninety percent of samples contained less than 3 mg/l and 99% less than 10 mg/l. Low levels (14-650 microgram/l) of CRP were detected both in amniotic fluids and in cerebrospinal fluids.

Adolescent↗

Fibronectin and C4-binding protein are selectively bound by aggregated amyloid P component.

Serum amyloid P component (SAP) is a normal plasma protein, closely related to C-reactive protein, which is deposited together with amyloid fibrils in all forms of amyloidosis. It is also a normal constituent of human tissues, where it is found in vascular basement membranes and in association with the peripheral microfibrillar mantle of elastic fibres throughout the body. Very similar, highly conserved, homologous proteins are present in the sera of all vertebrates in which they have been sought, and in all cases these proteins display calcium-dependent binding affinity for agarose. The physiological function or pathogenetic significance of this reactivity are not known but we report here for the first time that under appropriate conditions human SAP can also bind certain serum glycoproteins. SAP, which had been aggregated either by direct conjugation to CNBr-activated Sepharose beads, or by complexing with anti-SAP antibodies immobilized on such beads, selectively took up fibronectin and C4-binding protein from whole normal human serum. The reaction was calcium dependent and the two ligands were bound independently of each other or of other serum constituents. Experiments with isolated fibronectin and SAP complexed by anti-SAP-Sepharose indicated that close association of pairs of SAP molecules was required for fibronectin to be bound and that each SAP dimer was capable of taking up a single molecule of fibronectin. There was no evidence that SAP in its native state in the serum was complexed with either fibronectin or C4-binding protein. The present findings significantly extend knowledge of the properties of SAP and open the way to characterisation of its physiological ligand(s) and thence to elucidation of its function.

Amyloid↗

C-reactive protein fifty years on.

The discovery of C-reactive protein (CRP) half a century ago led to the description of the acute-phase reaction which is a fundamental response of the body to injury. Recent work on the structure and function of CRP has revealed the existence of a unique plasma protein family, including CRP and serum amyloid P component (SAP). These proteins have been conserved throughout vertebrate evolution. CRP binds specifically to a wide range of substances derived both from damaged autologous cells and from microorganisms. Complexed CRP can activate the complement system and, by virtue of its dramatically increased production in response to tissue injury, it probably acts primarily as a protective mechanism. However, in some circumstances CRP may also initiate or exacerbate inflammatory lesions. Clinical measurement of serum CRP is valuable as a screening test for organic disease and as a sensitive object index of disease activity and response to therapy in some inflammatory, infective, and ischaemic conditions. SAP closely resembles CRP in structure but not an acute-phase reactant in man. An apparently identical protein, amyloid P component (AP), is always found in amyloid deposits. AP is also found in normal tissues, as an integral constituent of vascular basement membranes and is located on the peripheral microfibrillar mantle of elastic fibres throughout the body.

Acute Disease↗

Epileptic discharges produced in monkeys by injection of spleen cells from rabbits immunised with monkey brain.

Cell suspension from the spleen of rabbits immunised with monkey brain gave rise to epileptic discharges in the monkey when injected intracortically, except in the case of one injection from a rabbit not recently given a booster treatment. In contrast, cell suspensions from the spleen of unimmunised rabbits, or of a rabbit immunised with a non-brain material, in all cases failed to be effective. The epileptic discharges began about 2 weeks after injection, were variable in frequency, and lasted throughout the period of recording.

Animals↗

Immunohistochemical demonstration of amyloid P component in skin of normal subjects and patients with cutaneous amyloidosis.

The presence of amyloid P component (AP) in dermal deposits of cutaneous amyloidosis was demonstrated by a direct immunofluorescence technique using an antibody to serum amyloid P component (SAP). AP was also shown, for the first time, to be a constituent of normal human skin. It was present at the periphery of dermal elastic tissue fibres, in basement membranes of dermal blood vessels and surrounding eccrine sweat glands but was absent from the dermo-epidermal basement membrane. The staining pattern in cutaneous amyloidosis was morphologically distinctive and readily distinguishable from staining of thickened vascular basement membranes in porphyria. Immunofluorescence with anti-SAP is simple and specific and may become the procedure of choice in the differential diagnosis of amyloidosis.

Amyloid↗

Delayed hypersensitivity reactions to Listeria monocytogenes in rats decomplemented with cobra factor and in C5-deficient mice.

The in vivo effect of cobra factor (CoF), the complement-activating protein of cobra (Naja naja) venom, was investigated, using quantifiable assays for localization of labelled donor lymphoblasts and of host macrophages in intraperitoneal and subcutaneous sites of injection of antigens from Listeria monocytogenes. Both commercially available (Cordis) and highly purified CoF impaired these inflammatory responses, suggesting that the complement-activating protein was itself responsible rather than lymphocytotoxic or other contaminants. CoF had no measurable effect on lymphoblast localization during the first 7 hr, and only a slight effect at 24 hr, whereas macrophage accumulation was reduced by about 50% at 24 hr. This suggests that CoF treatment affected non-specific components of the early inflammatory reaction but had little or no effect on the subsequent immunospecific reaction. The effect of CoF on macrophages may be direct, or via depletion of complement components acting on macrophages, such as factor B and/or C3 or fragments thereof. It does not seem to involve the terminal complement components, C5--C9, since neither delayed-type hypersensitivity (DTH) nor cellular resistance to Listeria was reduced in C5-deficient mice when compared with C5-sufficient congenic controls.

Animals↗

Enumeration of T and B lymphocytes in whole peripheral blood: absence of a null cell population.

Alkaline phosphatase-labelled F(ab')2 polyvalent anti-human immunoglobulin stained a mean of 12% (s.d. 4.2) of lymphocytes in the whole peripheral blood of 15 normal individuals. However, when the sensitivity of detection of the bound anti-immunoglobulin reagent was enhanced by adding complexes of alkaline phosphatase with F(ab')2 anti-alkaline phosphatase, a mean of 22.1% (s.d. 7.8) of lymphocytes were positive. The mean number of T lymphocytes demonstrated in the same blood samples using a monoclonal anti-T lymphocyte antibody (OKT3) was 78% (s.d. 4.1) and was not increased by immunoenzyme enhancement. In five individuals the blood was washed at 37 degrees C to remove passively adsorbed IgG and was then studied using the enhanced method together with monoclonal anti-kappa and anti-lambda antibodies. The mean +/- s.d. number of kappa-positive lymphocytes was 15.5 +/- 4.6% and lambda-positive was 7.9 +/- 1.1%. The sum of these was the same as the number of cells stained either with anti-kappa and anti-lambda together or with the conventional polyvalent anti-immunoglobulin, confirming that the enhancement procedure was detecting integral membrane immunoglobulin and not passively adsorbed IgG. Application to the same blood sample of both the anti-T cell antibody and the enhancement procedure with polyvalent anti-immunoglobulin stained 99-100% of lymphocytes. The present observations confirm that there are two populations among the B-lymphocytes, the B-major cells with readily demonstrable surface immunoglobulin and the B-minor cells on which surface immunoglobulin is demonstrable only by very sensitive techniques (Haegert & Coombs, 1979). The B-major and B-minor cells together account for all the non-T lymphocytes and there are virtually no so-called 'null' cells in normal peripheral blood. These findings have significant implications for the use of surface membrane immunoglobulin as a marker in the typing of normal and abnormal lymphocyte populations.

Adult↗

Agglutination of complement-coated erythrocytes by serum amyloid P-component.

Serum amyloid P-component (SAP) is a normal plasma glycoprotein apparently identical with the P-component associated with amyloid deposits. SAP shows extensive amino acid sequence homology with the C-reactive protein, and both have a similar molecular configuration. SAP undergoes calcium-dependent binding to zymosan, agarose, and amyloid fibrils, but its functional properties are not yet known. We report here that SAP agglutinates complement-(C) coated antibody-sensitized erythrocytes by a calcium-dependent reaction. SAP was found to interact predominantly with a modified form of bound C3b. This modification was achieved by prolonged treatment of EAC43 with heated normal human serum or with isolated C3bINA and beta 1H, and reactivity was reduced upon treatment of the cells with trypsin. SAP thus seems to react with fixed C3 in a manner similar to the reaction of C3 with bovine conglutinin, a molecule that also undergoes calcium-dependent binding to zymosan and agarose. These studies identify a new reactivity for SAP and demonstrate an interaction between an amyloid protein and the C system. The close similarity between the calcium-dependent binding specificities of SAP and of bovine conglutinin may assist in characterization of these molecules and in investigation of their function.

Agglutination↗

Amyloid P-component is a constituent of normal human glomerular basement membrane.

Glomerular and other vascular basement membranes were found to contain an antigen that was immunochemically indistinguishable from serum amyloid P-component. There was no immunological cross-reactivity between antisera to serum amyloid P-component and to collagen types I, III, IV, or V. The amyloid P-component antigen was confined to the endothelial aspect, the lamina rara interna, of glomerular basement membrane. It could not be eluted by high-ionic-strength saline, EDTA, dithiothreitol, or either polar or nonpolar detergents, but was released into solution when isolated glomerular basement membrane was digested by highly purified bacterial collagenase. Most of these P-component molecules and their constituent polypeptide chains were of higher molecular weight and lower isoelectric point than serum amyloid P-component. These findings indicate that, as well as being a normal plasma protein and a universal constituent of amyloid deposits, P-component is also a normal matrix glycoprotein of basement membrane in which it is covalently linked to collagen and/or other matrix proteins. This may be relevant both to the pathogenesis of amyloidosis and to other aspects of physiology and pathology of basement membranes.

Amyloid↗

Amyloid P-component in human glomerular basement membrane. Abnormal patterns of immunofluorescent staining in glomerular disease.

Serum amyloid P-component (SAP) is a normal plasma protein and is a constituent of normal human glomerular basement membrane. Immunofluorescence with anti-SAP antibody produced characteristic linear staining along the glomerular basement membrane in normal kidney. Distinctive abnormal staining patterns were seen in renal biopsy specimens from patients with diabetes, membranous glomerulonephritis, mesangiocapillary nephritis, systemic vasculitis, Goodpasture's syndrome.

Amyloid↗

Enumeration in whole peripheral blood of lymphocytes bearing receptors for Fc(gamma) and C3b using alkaline phosphatase-labelled reagents.

The whole blood method for enumeration of T and B lymphocyte populations using alkaline phosphatase-labelled reagents (Druguel and Pepys, 1977) has been extended to the quantitation of lymphocytes bearing receptors for Fc(gamma) and for C3b. This technique, by avoiding the variable loss of cells which is unavoidably associated with separation of mononuclear cells from blood, permits accurate measurement of the proportions and absolute numbers of circulating lymphocytes bearing these receptors. Fc(gamma) receptors were detected using complexes of alkaline phosphatase (AP) and eluted rabbit IgG anti-AP antibody. Receptors for C3b were detected using isolated human C3b followed by conjugates of AP with F(ab)2 of sheep anti-human C3 antibody. The mean +/- S.D. of Fc(gamma) receptor-positive lymphocytes among 16 normal adults was 11.8 +/- 2.5%, 248 +/- 113/microliter and among 17 normal adults the values for C3b receptor-positive lymphocytes was 9.4 +/- 2.0%, 208 +/- 101/microliter.

Alkaline Phosphatase↗

Radioimmunoassay for immunoconglutinins.

A competitive radioimmunoassay for immunoconglutinin (IK) was developed using isolated antostimulated rabbit IK labelled with 125I and glutaraldehyde-fixed sheep erythrocytes coated with fixed complement (EAC). IKs in test sera of human or animal origin produced specific inhibition of uptake of [125I]IK onto EAC and this was quantitated by reference to a calibration curve established with pure rabbit IK. Among 20 normal human sera the IK levels were: median 62 microgram/ml, range 41-170 microgram/ml and in 7 rat sera the levels were: median 71 microgram/ml, range 58-80 microgram/ml. Preliminary studies showed raised IK levels in the sera of patients with rheumatoid arthritis and with Crohn's disease.

Animals↗

Value of serum C-reactive protein measurement in the investigation of fever in systemic lupus erythematosus.

The concentration of C-reactive protein (CRP) in the sera of patients with systemic lupus erythematosus (SLE) was higher when the disease was active than when it was inactive, but was only markedly raised in patients suffering from identifiable microbial infection. CRP levels greater than 60 mg/l suggest the presence of intercurrent infection and may therefore be a valuable aid to the differential diagnosis of pyrexia in SLE.

C-Reactive Protein↗